RECCE PHARMACEUTICALS LTD - Announcements

1.28%

38.5¢

Market Cap $111.3M

Healthcare Biotechnology

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce... An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.More

Corporate Spotlight

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight

Recce accelerates commercialisation

Announcements

Filter Results

All Price Sensitive Only

RCE	Anti-viral Activity-RCE.AX	PRICE SENSITIVE	13/07/16	522.68KB	Share
RCE	Update on Testing Schedules-RCE.AX	PRICE SENSITIVE	21/06/16	457.94KB	Share
RCE	Appendix 3B-RCE.AX		14/06/16	545.5KB	Share
RCE	Appendix 3B-RCE.AX		07/06/16	752.98KB	Share
RCE	Pharma Executive Appointed to Recce Board-RCE.AX		27/05/16	213.66KB	Share
RCE	Encouraging Results from Safety Test-RCE.AX	PRICE SENSITIVE	25/05/16	641.67KB	Share
RCE	Shares to be released from Escrow-RCE.AX		23/05/16	218.64KB	Share
RCE	Director Appointment/Resignation-RCE.AX		16/05/16	381.59KB	Share
RCE	Shares to be Released from Escrow-RCE.AX		10/05/16	218.86KB	Share
RCE	Recce - The Way Forward-RCE.AX	PRICE SENSITIVE	03/05/16	256.24KB	Share
RCE	Appendix 4C - quarterly-RCE.AX	PRICE SENSITIVE	27/04/16	440.38KB	Share
RCE	Final Directors Interest Notice-RCE.AX		11/04/16	863.21KB	Share
RCE	Progress Update-RCE.AX	PRICE SENSITIVE	11/04/16	1.05MB	Share
RCE	International Trade Mark Registrations-RCE.AX	PRICE SENSITIVE	06/04/16	569.77KB	Share
RCE	Anti-cancer Activities	PRICE SENSITIVE	14/03/16	380.58KB	Share
RCE	Amendment to Appendix 3B		29/02/16	771.97KB	Share
RCE	Appendix 4D and Half Year Financial Statements	PRICE SENSITIVE	26/02/16	795.31KB	Share
RCE	Becoming a substantial holder		17/02/16	1.41MB	Share
RCE	Change of Director's Interest Notice		16/02/16	2.28MB	Share
RCE	Appendix 3B		16/02/16	755.53KB	Share
RCE	Conversion of Performance Shares		16/02/16	183.78KB	Share
RCE	Efficacy without Toxicity	PRICE SENSITIVE	02/02/16	259.36KB	Share
RCE	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/16	417.37KB	Share
RCE	Becoming a substantial holder		28/01/16	419.41KB	Share
RCE	RECCE Antibiotic kills TB and Gonorrhoea	PRICE SENSITIVE	27/01/16	228.45KB	Share
RCE	Becoming a substantial holder		25/01/16	1.46MB	Share
RCE	Becoming a substantial holder		25/01/16	1.36MB	Share
RCE	Broker Presentation		18/01/16	2.84MB	Share
RCE	Initial Director's Interest Notice		15/01/16	210.61KB	Share
RCE	Initial Director's Interest Notice		15/01/16	211.98KB	Share
RCE	Initial Director's Interest Notice		15/01/16	210.18KB	Share
RCE	Initial Director's Interest Notice		15/01/16	210.67KB	Share
RCE	Initial Director's Interest Notice		15/01/16	210.51KB	Share
RCE	RECCE Antiobiotic Equal/Better than Commercial Antibiotic		15/01/16	190.39KB	Share
RCE	RECCE Trademark Registered		15/01/16	107.2KB	Share
RCE	Additional Patent Developments	PRICE SENSITIVE	15/01/16	105.81KB	Share
RCE	Patent Granted in China	PRICE SENSITIVE	15/01/16	107.97KB	Share
RCE	Patent Family Confirmations		13/01/16	185.55KB	Share
RCE	Terms and conditions of Company's performance shares		13/01/16	24.05KB	Share
RCE	Restricted Securities Statement		13/01/16	220.23KB	Share
RCE	Securities Trading Policy		13/01/16	207.99KB	Share
RCE	Finncial Accounts - 30 June 2013, 30 June 2014, 30 June 2015		13/01/16	14.85MB	Share
RCE	Constitution		13/01/16	427.45KB	Share
RCE	Prospectus		13/01/16	2.34MB	Share
RCE	Appendix 1A and Information Form and Checklist		13/01/16	704.92KB	Share
RCE	Top 20 shareholders		13/01/16	44.81KB	Share
RCE	Distribution Schedule		13/01/16	44.09KB	Share
RCE	Pre-Quotation Disclosure		13/01/16	112.67KB	Share
RCE	ASX Notice		13/01/16	291.22KB	Share
RCE	Admission to Official List	PRICE SENSITIVE	13/01/16	110.23KB	Share
RCE	IPO Oversubscribed		30/12/15	185.95KB	Share
RCE	Supplementary Prospectus		25/11/15	54.69KB	Share
RCE	Further extension of Offer to 30 October 2015		21/10/15	88.03KB	Share
RCE	Extension of Prospectus Offer Period		14/10/15	88.04KB	Share
RCE	Recce Limited - Financial Report for FY 30 June 2013		23/09/15	4.87MB	Share
RCE	Recce Limited - Financial Report for FY 30 June 2015		23/09/15	4.99MB	Share
RCE	Recce Limited - Financial Report for FY 30 June 2014		23/09/15	4.99MB	Share
RCE	Recce Limited - Replacement Prospectus		23/09/15	2.46MB	Share
RCE	Recce Limited - Prospectus		14/09/15	5.77MB	Share

RCE Anti-viral Activity-RCE.AX
13/07/16	PRICE SENSITIVE	522.68KB	Share
RCE Update on Testing Schedules-RCE.AX
21/06/16	PRICE SENSITIVE	457.94KB	Share
RCE Appendix 3B-RCE.AX
14/06/16		545.5KB	Share
RCE Appendix 3B-RCE.AX
07/06/16		752.98KB	Share
RCE Pharma Executive Appointed to Recce Board-RCE.AX
27/05/16		213.66KB	Share
RCE Encouraging Results from Safety Test-RCE.AX
25/05/16	PRICE SENSITIVE	641.67KB	Share
RCE Shares to be released from Escrow-RCE.AX
23/05/16		218.64KB	Share
RCE Director Appointment/Resignation-RCE.AX
16/05/16		381.59KB	Share
RCE Shares to be Released from Escrow-RCE.AX
10/05/16		218.86KB	Share
RCE Recce - The Way Forward-RCE.AX
03/05/16	PRICE SENSITIVE	256.24KB	Share
RCE Appendix 4C - quarterly-RCE.AX
27/04/16	PRICE SENSITIVE	440.38KB	Share
RCE Final Directors Interest Notice-RCE.AX
11/04/16		863.21KB	Share
RCE Progress Update-RCE.AX
11/04/16	PRICE SENSITIVE	1.05MB	Share
RCE International Trade Mark Registrations-RCE.AX
06/04/16	PRICE SENSITIVE	569.77KB	Share
RCE Anti-cancer Activities
14/03/16	PRICE SENSITIVE	380.58KB	Share
RCE Amendment to Appendix 3B
29/02/16		771.97KB	Share
RCE Appendix 4D and Half Year Financial Statements
26/02/16	PRICE SENSITIVE	795.31KB	Share
RCE Becoming a substantial holder
17/02/16		1.41MB	Share
RCE Change of Director's Interest Notice
16/02/16		2.28MB	Share
RCE Appendix 3B
16/02/16		755.53KB	Share
RCE Conversion of Performance Shares
16/02/16		183.78KB	Share
RCE Efficacy without Toxicity
02/02/16	PRICE SENSITIVE	259.36KB	Share
RCE Appendix 4C - quarterly
29/01/16	PRICE SENSITIVE	417.37KB	Share
RCE Becoming a substantial holder
28/01/16		419.41KB	Share
RCE RECCE Antibiotic kills TB and Gonorrhoea
27/01/16	PRICE SENSITIVE	228.45KB	Share
RCE Becoming a substantial holder
25/01/16		1.46MB	Share
RCE Becoming a substantial holder
25/01/16		1.36MB	Share
RCE Broker Presentation
18/01/16		2.84MB	Share
RCE Initial Director's Interest Notice
15/01/16		210.61KB	Share
RCE Initial Director's Interest Notice
15/01/16		211.98KB	Share
RCE Initial Director's Interest Notice
15/01/16		210.18KB	Share
RCE Initial Director's Interest Notice
15/01/16		210.67KB	Share
RCE Initial Director's Interest Notice
15/01/16		210.51KB	Share
RCE RECCE Antiobiotic Equal/Better than Commercial Antibiotic
15/01/16		190.39KB	Share
RCE RECCE Trademark Registered
15/01/16		107.2KB	Share
RCE Additional Patent Developments
15/01/16	PRICE SENSITIVE	105.81KB	Share
RCE Patent Granted in China
15/01/16	PRICE SENSITIVE	107.97KB	Share
RCE Patent Family Confirmations
13/01/16		185.55KB	Share
RCE Terms and conditions of Company's performance shares
13/01/16		24.05KB	Share
RCE Restricted Securities Statement
13/01/16		220.23KB	Share
RCE Securities Trading Policy
13/01/16		207.99KB	Share
RCE Finncial Accounts - 30 June 2013, 30 June 2014, 30 June 2015
13/01/16		14.85MB	Share
RCE Constitution
13/01/16		427.45KB	Share
RCE Prospectus
13/01/16		2.34MB	Share
RCE Appendix 1A and Information Form and Checklist
13/01/16		704.92KB	Share
RCE Top 20 shareholders
13/01/16		44.81KB	Share
RCE Distribution Schedule
13/01/16		44.09KB	Share
RCE Pre-Quotation Disclosure
13/01/16		112.67KB	Share
RCE ASX Notice
13/01/16		291.22KB	Share
RCE Admission to Official List
13/01/16	PRICE SENSITIVE	110.23KB	Share
RCE IPO Oversubscribed
30/12/15		185.95KB	Share
RCE Supplementary Prospectus
25/11/15		54.69KB	Share
RCE Further extension of Offer to 30 October 2015
21/10/15		88.03KB	Share
RCE Extension of Prospectus Offer Period
14/10/15		88.04KB	Share
RCE Recce Limited - Financial Report for FY 30 June 2013
23/09/15		4.87MB	Share
RCE Recce Limited - Financial Report for FY 30 June 2015
23/09/15		4.99MB	Share
RCE Recce Limited - Financial Report for FY 30 June 2014
23/09/15		4.99MB	Share
RCE Recce Limited - Replacement Prospectus
23/09/15		2.46MB	Share
RCE Recce Limited - Prospectus
14/09/15		5.77MB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 38.5¢		Change -0.005(1.28%)		Mkt cap ! $111.3M

Open	High	Low	Value	Volume
38.5¢	38.5¢	37.0¢	$21.54K	57.86K

Buyers (Bids)

No.	Vol.	Price($)
1	3248	37.5¢

Sellers (Offers)

Price($)	Vol.	No.
39.0¢	49884	1

View Market Depth

No.	Vol.	Price($)
1	3248	0.375
1	2000	0.370
3	38185	0.365
2	71806	0.360
2	85000	0.355

Price($)	Vol.	No.
0.390	49884	1
0.400	23104	2
0.410	25471	1
0.440	8669	2
0.450	20976	3

Last trade - 14.27pm 30/07/2025 (20 minute delay)


Last 38.0¢		Change -0.005 ( 0.58 %)
Open	High	Low	Volume
38.5¢	38.5¢	37.0¢	25811
Last updated 12.59pm 30/07/2025 ?

RCE (ASX) Chart

RECCE PHARMACEUTICALS LTD - Announcements

Corporate Spotlight

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories